In partnership with
10 Stocks Built for Growth and Income
There’s still room for growth in the market in 2026, and the all-new 10 Best Stocks to Own: Fall 2026 list is built for balance and upside.
Inside, you’ll find reliable dividend growers built to generate income...
Plus high-growth names positioned to benefit from some of the market’s biggest trends.
From AI infrastructure and energy to consumer growth and capital returns, these 10 stocks offer different ways to pursue opportunity this fall.
You don’t have to choose between income and growth.
See the 10 stocks positioned to offer both and get the full report while it’s still free.
Friday tape: labor stays firm, DC rewrites the rules around science and AI risk, and the trade map keeps shifting south. Position accordingly.
Image via Fox Business
October Jobs: 165K And The Fed Can’t Exhale
Payrolls came in at 165,000 for October, a clean beat in a market that’s been leaning into the "soft landing means cuts" trade. In plain English: employers are still hiring through the noise, which keeps the floor under consumption and the ceiling over near-term rate cuts.
This is the part equity bulls always miss in real time: stronger jobs is good for earnings, but it’s also permission for the Fed to stay restrictive longer. That pushes real yields up, tightens financial conditions, and forces multiple compression on anything priced off distant cash flows.
Watch the market’s first reaction versus the close. If yields catch a bid and the dollar firms, mega-cap growth and speculative software get clipped, while value, banks, and energy hold up better. Crypto tends to trade like levered liquidity, so don’t be shocked if it fades on higher front-end expectations.
📈 Fred's Take: 165K keeps the Fed in control of the calendar, not Wall Street. The path of least resistance is fewer cuts, later cuts, and a market that has to re-price duration risk again. If you’re long high-multiple growth like it’s 2021, this print is a reminder: labor strength is not your friend when rates are the constraint.
Image via The Hill
Congress And The Science Budget: This Is An Industrial Policy Trade, Not A Feel-Good Story
The Hill is framing it plainly: America’s scientific future is a Congressional decision now, driven by funding, oversight, and the ability to rebuild capacity that’s been hollowed out. This isn’t abstract. It’s labs, grants, talent pipelines, procurement, and the difference between leading and licensing.
Markets should read this as the next leg of industrial policy. If Congress stabilizes funding and stops governing by continuing resolution, you get longer duration project planning, more commercialization, and a clearer revenue runway for the suppliers: instruments, specialty chemicals, contract research, advanced manufacturing tooling, and select semis tied to research ecosystems.
If Congress doesn’t, the U.S. bleeds researchers, timelines slip, and the private sector prices in higher regulatory and funding volatility. That’s a discount rate story, not a morality play.
📈 Fred's Take: The science fight is a capital allocation fight. Fund it consistently and you compound national productivity, which is bullish for real growth and for the parts of the market that monetize R&D. Starve it and you’re choosing a slower GDP trend, more dependence on foreign IP, and a market that overpays for scarcity winners while the broader economy underperforms.
📎 The Hill
Dem Senate Knife Fight: Schumer Drama Means Messy Policy, Not Clean Deals
Daily Wire reports a brewing internal battle as new Democratic senators look to move past Chuck Schumer. Translation: the caucus is pulling in different directions, and leadership fights always eat oxygen that could have gone to legislating.
For markets, party civil wars usually show up as process risk. Committees stall, calendars slip, and whatever policy does move tends to get stuffed into must-pass vehicles at the last second. That increases headline volatility around shutdowns, debt-limit theatrics, and surprise amendments that hit specific industries.
The other angle: leadership uncertainty changes donor flows and lobbying priorities fast. When the power map is unclear, corporate America hedges, and that means delayed capex decisions and a higher political risk premium in regulated sectors like health care, banks, energy, and big tech.
📈 Fred's Take: A divided caucus is bullish gridlock, but bearish execution. The base case becomes fewer big legislative swings, which helps risk assets, yet you get more cliff events and ugly brinkmanship, which helps volatility sellers until it doesn’t. If you trade this right, you stay long quality, keep hedges cheap, and don’t assume Washington can deliver "clean" anything.
Image via Roll Call
AI Financial Risk Bill: Regulators Want A New Dashboard, And Wall Street Will Pay For It
Roll Call highlights a bill from Rep. Bill Foster aimed at boosting the tech regulators use to monitor AI-driven financial risks. The premise is straightforward: the system got more complex, the supervisory tools didn’t, and nobody wants to be the guy explaining the next flash event was "an AI thing" they couldn’t see.
This pushes two market levers at once. First, compliance spend rises: data lineage, model governance, audit trails, and real-time monitoring. Second, it puts a spotlight on model-driven trading, underwriting, and credit decisions, which could tighten permissible risk-taking at the margin.
Winners are the boring picks: regtech, data infrastructure, cybersecurity, and enterprise software tied to reporting and controls. Losers are firms that treated AI as a black box because it boosted returns, not because it was safe.
📈 Fred's Take: This is the inevitable pivot from "innovate" to "document." The bill is a tailwind for compliance tech and a headwind for anyone relying on opacity as an edge. Net-net, it reduces left-tail risk over time, but in the short run it’s higher costs, slower deployment, and more regulatory headlines that can hit the most aggressive financial names.
Image via Forbes
Mexico Nears $1 Trillion In U.S. Trade: The Real Winner Is North American Supply Chains
Forbes says Mexico is on track to become the first $1 trillion U.S. trade partner in 2026, taking the biggest share of U.S. trade since 2008. That is the scoreboard for nearshoring, friend-shoring, and the quiet rewiring of manufacturing away from long, fragile routes.
This matters because it’s not just autos and appliances anymore. It’s electronics assembly, aerospace components, medical devices, and an expanding logistics web that drags rail, trucking, industrial REITs, border infrastructure, and regional banks along with it.
It also feeds back into inflation and rates. Shorter supply chains can reduce some volatility, but heavy infrastructure buildout and wage pressures in the corridor can keep a floor under goods prices and construction inputs. The market implication is mixed: better resilience, but not necessarily cheap.
📈 Fred's Take: Mexico hitting a trillion isn’t a headline, it’s a regime. Own the picks-and-shovels of North American production: transport, warehouses, grid buildout, and select industrials with real pricing power. The bigger point: geopolitics is now a line item in your margin model, and North America is where the market is placing its long-term bet.
📎 Forbes
That’s the tape. Trade the facts, hedge the politics, and don’t argue with the rate market. Fred Frost, Morning Bullets
— Fred Frost
